Patient Safety
Quality Resources
Discover more efficient office practices and risk management strategies for increasing your patients' safety.
FDA AND CDC NOTIFICATIONS
FDA Drug Safety and Labeling Changes Database
Recent Drug and Device Alerts
- Medtronic Recalls StealthStation S8 Application Versions 1.2.0, 1.1.0, 1.0.3, 1.0.2, and 1.0.1 for Software Error that May Cause Incorrect Measurements During Cranial Surgery
- Medtronic Neurosurgery Recalls Duet External Drainage and Monitoring System Catheter Tubing due to a Potential for the Catheter Disconnection from the Patient Line Stopcock Connectors
- ResMed Ltd. Recalls Continuous Positive Airway Pressure (CPAP) Masks with Magnets Due to Possible Magnetic Interference with Certain Medical Devices
- FDA warns of rare but serious drug reaction to antiseizure medicines levetiracetam and clobazam
ABUSE AND VIOLENCE
Screening for abuse and violence in patients with neurologic conditions is important. The American Academy of Neurology retired the 2012 abuse and violence position statement to allow flexibility in meeting individual provider needs and promotion of resources in this rapidly changing landscape. The following resources are provided to help you identify the appropriate screening method and frequency for your patient population:
- For Survivors of Intimate Partner Violence, Overlooked Brain Injuries Take a Toll
- Partner Violence and Abuse of Elderly and Vulnerable Adults: Screening
- American Academy of Family Physicians Detecting Elder Abuse and Neglect: Assessment and Intervention
- AMA Preventing, Identifying & Treating Violence & Abuse
- American Academy of Family Physicians Intimate Partner Violence
- American Academy of Pediatrics Council on Child Abuse and Neglect
OLDER DRIVER SAFETY
- The Physician's Guide to Assessing and Counseling Older Drivers from the American Medical Association, in collaboration with the National Highway Traffic Safety Administration.
- AAN's Guideline for the Assessment of Driving Risk in Patients with Dementia
- AAN's quality measure for Driving Screening and Follow-Up for Patients with Dementia